WO2025238559 - METHOD OF MAKING UDENAFIL AND INTERMEDIATES THEREOF
National phase entry is expected:
Publication Number
WO/2025/238559
Publication Date
20.11.2025
International Application No.
PCT/IB2025/055022
International Filing Date
13.05.2025
Title **
[English]
METHOD OF MAKING UDENAFIL AND INTERMEDIATES THEREOF
[French]
PROCÉDÉ DE FABRICATION D'UDÉNAFIL ET D'INTERMÉDIAIRES DE CELUI-CI
Applicants **
MEZZION PHARMA CO., LTD.
Inventors
SZULC, Marcin
SZRAMKA, Roman
KRZYŻANOWSKI, Mariusz
Priority Data
63/646,028
13.05.2024
US
63/709,210
18.10.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4039 | |
| EPO | Filing, Examination, Granting | 46115 | |
| Japan | Filing, Examination, Granting | 3696 | |
| South Korea | Filing, Examination, Granting | 5063 | |
| USA | Filing, Examination, Granting | 13990 |
Total:
72,903
Contact Us
Abstract[English]
The present disclosure relates to methods of making udenafil and intermediates thereof.[French]
La présente divulgation concerne des procédés de fabrication d'udénafil et d'intermédiaires de celui-ci.